BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laitakari A, Liu L, Frimurer TM, Holst B. The Zinc-Sensing Receptor GPR39 in Physiology and as a Pharmacological Target. Int J Mol Sci 2021;22:3872. [PMID: 33918078 DOI: 10.3390/ijms22083872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Villarreal D, Pradhan G, Zhou Y, Xue B, Sun Y. Diverse and Complementary Effects of Ghrelin and Obestatin. Biomolecules 2022;12:517. [DOI: 10.3390/biom12040517] [Reference Citation Analysis]
2 Doboszewska U, Sawicki J, Sajnóg A, Szopa A, Serefko A, Socała K, Pieróg M, Nieoczym D, Mlyniec K, Nowak G, Barałkiewicz D, Sowa I, Wlaź P. Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy—The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene. Cells 2022;11:1987. [DOI: 10.3390/cells11131987] [Reference Citation Analysis]
3 Xu Y, Barnes AP, Alkayed NJ. Role of GPR39 in Neurovascular Homeostasis and Disease. Int J Mol Sci 2021;22:8200. [PMID: 34360964 DOI: 10.3390/ijms22158200] [Reference Citation Analysis]
4 Henze LA, Estepa M, Pieske B, Lang F, Eckardt KU, Alesutan I, Voelkl J. Zinc Ameliorates the Osteogenic Effects of High Glucose in Vascular Smooth Muscle Cells. Cells 2021;10:3083. [PMID: 34831306 DOI: 10.3390/cells10113083] [Reference Citation Analysis]